Delivery Order SPE2DB25D7056-SPE2DB25FTMFE

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,855.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of Phytonadione 10 mg/ml ampule, a medication used to treat vitamin K deficiency. The contract has a firm fixed-price pricing type and is not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,289.64, is for the delivery of 4,567,442,998 units of the medication phytonadione 1 mg/0.5 ml syringe. The contract has a firm fixed price and an ultimate completion date of March 4, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific award has a ceiling...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,031.76, is for the supply of 4564713474 Phytonadione 1 mg/0.5 ml syrup 0.5 ml. The delivery order is placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,060,794 units of the medication Phytonadione 1 mg/0.5 ml syringe, with a ceiling value of $8,647.82. The award has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DX15D6028|SPE2DX25FWLED, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,532.73 firm-fixed-price delivery order is for the supply of 4568031837 - Phytonadione .5ML 10S, a medical product. This award is not set-aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides comprehensive global...
This federal contract award, valued at $2,143.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of PHYTONADIONE 10 MG/ML AMPULML, a medication, with a performance period ending on April 8, 2025. The contract is a Firm Fixed Price agreement, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,233.96, is for the delivery of phytonadione 1 mg/0.5 ml syrup. It is a firm fixed-price delivery order with an ultimate completion date of April 15, 2025. The contract was awarded on April 14, 2025 and is not associated with a set-aside designation. As a leading vendor for federal healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,826.26, is for the delivery of Phytonadione 5 mg tablet in 100-count bottles. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,426.64 firm fixed-price delivery order is for the supply of 4565711529 - Phytonadione 1 mg/0.5 ml syrup, 0.5 ml. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB25D7056
    Indefinite Delivery Contract
  • SPE2DB25D7056-SPE2DB25FTMFE
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide phytonadione 10 mg/ml ampules. The contract has a ceiling value of $2,838.75 and an ultimate completion date of April 14, 2025. This appears to be a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this specific award.

Generated 7/11/25, 9:52 AM